Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort-Reference-Cited by-同舟云学术

Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort

Published:2022-02-03 Issue:3 Volume:39 Page:1432-1445
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Pollock Carol^ORCID,James Glen^ORCID,Garcia Sanchez Juan Jose,Arnold Matthew,Carrero Juan-Jesus,Lam Carolyn S. P.,Chen Hungta,Nolan Stephen,Pecoits-Filho Roberto

Funder

AstraZeneca

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-021-02010-3.pdf

Reference51 articles.

1. GBD Chronic Kidney Disease Collaboration. Global, Regional, and National Burden of Chronic Kidney Disease, 1990–2017: A systematic analysis for the global burden of disease study 2017. Lancet (Lond, Engl). 2020;395:709–33.

2. Jager KJ, Kovesdy C, Langham R, et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transpl: official publication of the European Dialysis and Transplant Association- European Renal Association. 2019;34:1803–5.

3. Stevens LA, Viswanathan G, Weiner DE. Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis. 2010;17:293–301.